Home
Storia in 1 fonti
Continuous Manufacturing Strategies for Scalable mAb Production
Explore how continuous manufacturing strategies can support more scalable, efficient, and cost-effective mAb production. Download this free whitepaper for insights into process integration, regulatory considerations, and long-term biologics manufacturing success. | Explore how continuous manufacturing strategies can support more scalable, efficient, and cost-effective mAb production. Download this free whitepaper for insights into process integration, regulatory considerations, and long-term biologics manufacturing success.
Raccontata da
fiercepharma.com
Timeline cronologica
- ·
With Elahere building steam, AbbVie nets FDA nod for another ImmunoGen cancer asset
As AbbVie continues to capitalize on its deal for ImmunoGen with the growth of commercial antibody-drug conjugate (ADC) Elahere, another of the acquired company’s clinical assets…
- ·
Continuous Manufacturing Strategies for Scalable mAb Production
Explore how continuous manufacturing strategies can support more scalable, efficient, and cost-effective mAb production. Download this free whitepaper for insights into process…
- ·
Fierce Pharma Asia—More China biotech hawkishness; Pfizer’s $10B Innovent deal; Astellas’ roadmap
As China-developed assets gain more attention from biopharma dealmakers, some industry watchers want to cur | As China-developed assets gain more attention from biopharma…